CAG repeat size in Huntingtin alleles is associated with cancer prognosis

[1]  Anne Vincent-Salomon,et al.  Unraveling the Role of Huntingtin in Breast Cancer Metastasis. , 2015, Journal of the National Cancer Institute.

[2]  S. Humbert,et al.  Huntingtin Regulates Mammary Stem Cell Division and Differentiation , 2014, Stem cell reports.

[3]  M. Hayden,et al.  Evidence‐based genetic counselling implications for Huntington disease intermediate allele predictive test results , 2014, Clinical genetics.

[4]  M. Hayden,et al.  Multisource ascertainment of Huntington disease in Canada: Prevalence and population at risk , 2014, Movement disorders : official journal of the Movement Disorder Society.

[5]  M. Hayden,et al.  CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease , 2013, Journal of Medical Genetics.

[6]  J. Jankovic,et al.  Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS , 2013, Neurology.

[7]  Wei Lu,et al.  Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer , 2013, Nature Genetics.

[8]  L. Smeeth,et al.  Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[9]  S. Tezenas du Montcel,et al.  The Huntington disease protein accelerates breast tumour development and metastasis through ErbB2/HER2 signalling , 2013, EMBO molecular medicine.

[10]  S. Vacher,et al.  Quantification of PKC family genes in sporadic breast cancer by qRT‐PCR: Evidence that PKCι/λ overexpression is an independent prognostic factor , 2012, International journal of cancer.

[11]  M. MacDonald,et al.  CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion , 2012, Neurology.

[12]  Jan Sundquist,et al.  Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden. , 2012, The Lancet. Oncology.

[13]  D. Easton,et al.  Evaluation of Association Methods for Analysing Modifiers of Disease Risk in Carriers of High‐Risk Mutations , 2012, Genetic epidemiology.

[14]  O. Lidegaard.  28 REPRODUCTIVE FACTORS AND BREAST CANCER , 2012 .

[15]  Pj Morrison,et al.  Uptake of Huntington disease predictive testing in a complete population , 2011, Clinical genetics.

[16]  Christiana Kartsonaki,et al.  A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population , 2010, Nature Genetics.

[17]  F. Couch,et al.  RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. , 2007, American journal of human genetics.

[18]  Georgia Chenevix-Trench,et al.  An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA) , 2007, Breast Cancer Research.

[19]  H. Lehrach,et al.  A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. , 2004, Molecular cell.

[20]  W. Foulkes,et al.  BRCA1 and BRCA2: 1994 and beyond , 2004, Nature Reviews Cancer.

[21]  I. Bièche,et al.  Quantification of estrogen receptor α and β expression in sporadic breast cancer , 2001, Oncogene.

[22]  K Fenger,et al.  Significantly lower incidence of cancer among patients with Huntington disease , 1999, Cancer.

[23]  P S Harper,et al.  Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. , 1996, American journal of human genetics.

[24]  M. MacDonald,et al.  Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease , 1993, Nature Genetics.

[25]  M. Hayden,et al.  The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease , 1993, Nature Genetics.

[26]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[27]  S. Humbert,et al.  Huntingtin: here, there, everywhere! , 2013, Journal of Huntington's disease.

[28]  E. Chiu,et al.  Problems assessing uptake of Huntington disease predictive testing and a proposed solution , 2009, European Journal of Human Genetics.